Regional Differences in Opioid Prescribing in Germany – Results of an Analysis of Health Insurance Data of 57 Million Adult People

References

• World Health Organization (WHO). World Health Organization Model List of Essential Medicines, 21st List; 2019.
   Google Scholar
• Wiffen PJ, Wee B, Derry S, et al. Opioids for cancer pain - an overview of cochrane reviews. Cochrane Database Syst Rev. 2017;7:CD012592. doi:10.1002/14651858.CD012592.pub2
   PubMed Web of Science ®Google Scholar
• Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain—United States, 2016. JAMA. 2016;315:1624. doi:10.1001/jama.2016.1464
   PubMed Web of Science ®Google Scholar
• Schubert I, Ihle P, Sabatowski R. Increase in opiate prescription in Germany between 2000 and 2010: a study based on insurance data. Dtsch Arztebl Int. 2013;110:45–51. doi:10.3238/arztebl.2013.0045
   PubMed Web of Science ®Google Scholar
• Rosner B, Neicun J, Yang JC, Roman-Urrestarazu A. Opioid prescription patterns in Germany and the global opioid epidemic: systematic review of available evidence. PLoS One. 2019;14(8):e0221153. doi:10.1371/journal.pone.0221153
   PubMed Web of Science ®Google Scholar
• Busse R, Blümel M. Germany. Health system review. European Observatory on Health Systems and Policies. Health Syst Transit. 2014;16(2).
   Google Scholar
• Bosetti C, Santucci C, Radrezza S, et al. Trends in the consumption of opioids for the treatment of severe pain in Europe, 1990–2016. Eur J Pain. 2018. doi:10.1002/ejp.1337
   Web of Science ®Google Scholar
• Curtis HJ, Croker R, Walker AJ, et al. Opioid prescribing trends and geographical variation in England, 1998–2018: a retrospective database study. Lancet Psychiatry. 2019;6(2):140–150. doi:10.1016/S2215-0366(18)30471-1
   PubMed Web of Science ®Google Scholar
• Paulozzi LJ, Jones CM, Mack KA, Rudd RA. Vital signs: overdoses of prescription opioid pain relievers — United States, 1999–2008. MMWR Morb Mortal Wkly Rep. 2011;60:1487–1492.
   PubMedGoogle Scholar
• Fischer B, Jones W, Urbanoski K, et al. Correlations between prescription opioid analgesic dispensing levels and related mortality and morbidity in Ontario, Canada, 2005–2011. Drug Alcohol Rev. 2014;33(1):19–26. doi:10.1111/dar.12089
   PubMed Web of Science ®Google Scholar
• Dunn KM, Saunders KW, Rutter CM, et al. Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med. 2010;152(2):85. doi:10.7326/0003-4819-152-2-201001190-00006
   PubMed Web of Science ®Google Scholar
• Kolodny A, Courtwright DT, Hwang CS, et al. The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction. Annu Rev Public Health. 2015;36(1):559–574. doi:10.1146/annurev-publhealth-031914-122957
   PubMed Web of Science ®Google Scholar
• Vowles KE, McEntee ML, Julnes PS, et al. Rates of opioid misuse, abuse, and addiction in chronic pain. Pain. 2015;156(4):569–576. doi:10.1097/01.j.pain.0000460357.01998.f1
   PubMed Web of Science ®Google Scholar
• Just JM, Schwerbrock F, Bleckwenn M, et al. Opioid use disorder in chronic non-cancer pain in Germany: a cross sectional study. BMJ Open. 2019;9:e026871. doi:10.1136/bmjopen-2018-026871
   Web of Science ®Google Scholar
• United Nations International Narcotics Control Board Narcotic Drugs Estimated World Requirements for 2019 Statistics for 2017. Available from: https://www.incb.org/documents/Narcotic-Drugs/Technical-Publications/2018/INCB-Narcotics_Drugs_Technical_Publication_2018.pdf. Accessed September 1, 2020.
   Google Scholar
• McDonald DC, Carlson K, Izrael D. Geographic variation in opioid prescribing in the U.S. J Pain. 2012;13(10):988–996. doi:10.1016/j.jpain.2012.07.007
   PubMed Web of Science ®Google Scholar
• Chen TC, Chen LC, Kerry M, Knaggs RD. Prescription opioids: regional variation and socioeconomic status – evidence from primary care in England. Int J Drug Policy. 2019;64:87–94. doi:10.1016/j.drugpo.2018.10.013
   PubMed Web of Science ®Google Scholar
• Lund BC, Ohl ME, Hadlandsmyth K, Mosher HJ. Regional and rural–urban variation in opioid prescribing in the veterans health administration. Mil Med. 2019;184(11–12):894–900. doi:10.1093/milmed/usz104
   Web of Science ®Google Scholar
• Degenhardt L, Gisev N, Cama E, et al. The extent and correlates of community-based pharmaceutical opioid utilisation in Australia. Pharmacoepidemiol Drug Saf. 2016;25(5):521–538. doi:10.1002/pds.3931
   PubMed Web of Science ®Google Scholar
• Hoffmann F, Glaeske G, Windt R. Prescription of high-potency opioids in 2011. Schmerz. 2012;26:707–714. German. doi:10.1007/s00482-012-1240-7
   Web of Science ®Google Scholar
• German Institute of Medical Documentation and Information (DIMDI) Information system for health care data (data transparency). Available from: https://www.dimdi.de/dynamic/en/further-services/health-care-data/. Accessed April 7, 2019.
   Google Scholar
• The Federal Institute for Research on Building Urban Affairs and Spatial Development. District reform in Mecklenburg-Western Pomerania; 2011. Available from: https://www.bbsr.bund.de/BBSR/DE/Raumbeobachtung/Raumabgrenzungen/deutschland/kreisgebietsreformen/KreisreformMeckPomm.html. Accessed May 17, 2019.
   Google Scholar
• Böger R, Schmidt G. Analgetika. In: Schwabe U, Paffrath D, editors. Arzneiverordnungs-Report 2011. Berlin, Heidelberg: Springer Berlin Heidelberg; 2011:261–278.
   Google Scholar
• The Federal Institute for Research on Building Urban Affairs and Spatial Development. Location indicator 2010. Available from: https://www.bbsr.bund.de/BBSR/DE/Raumbeobachtung/Downloads/downloads_node.html. Accessed September 1, 2020.
   Google Scholar
• Kühn M. Peripherien in der räumlichen Planung und Politik. In: Kühn M, editor. Peripherisierung und Stadt. Bielefeld: transcript Verlag; 2016:41–58. [Book in German]
   Google Scholar
• Paulozzi LJ, Mack KA, Hockenberry JM. Variation among states in prescribing of opioid pain relievers and benzodiazepines - United States, 2012. J Safety Res. 2014;51:125–129. doi:10.1016/j.jsr.2014.09.001
   PubMed Web of Science ®Google Scholar
• Todd A, Akhter N, Cairns JM, et al. The pain divide: a cross-sectional analysis of chronic pain prevalence, pain intensity and opioid utilisation in England. BMJ Open. 2018;8(7):e023391. doi:10.1136/bmjopen-2018-023391
   Web of Science ®Google Scholar
• Möller J, Laflamme L, Söderberg Löfdal K. CYP2D6-inhibiting drugs and the increased risk of fall-related injuries due to newly initiated opioid treatment - A Swedish, register-based case-crossover study. Basic Clin Pharmacol Toxicol. 2015;116(2):134–139. doi:10.1111/bcpt.12289
   Web of Science ®Google Scholar
• Brouquet A, Cudennec T, Benoist S, et al. Impaired mobility, ASA status and administration of tramadol are risk factors for postoperative delirium in patients aged 75 years or more after major abdominal surgery. Ann Surg. 2010;251(4):759–765. doi:10.1097/SLA.0b013e3181c1cfc9
   Web of Science ®Google Scholar
• Radbruch L, Glaeske G, Grond S, et al. Topical review on the abuse and misuse potential of tramadol and tilidine in Germany. Subst Abus. 2013;34:313–320. doi:10.1080/08897077.2012.735216
   PubMed Web of Science ®Google Scholar
• Garbe E, Jobski K, Schmid U. Utilisation of transdermal fentanyl in Germany from 2004 to 2006. Pharmacoepidemiol Drug Saf. 2012;21:191–198. doi:10.1002/pds.2164
   Web of Science ®Google Scholar
• Kenan K, Mack K, Paulozzi L. Trends in prescriptions for oxycodone and other commonly used opioids in the United States, 2000–2010. Open Med. 2012;6:e41–7.
   PubMedGoogle Scholar
• Sears JM, Edmonds AT, Fulton-Kehoe D. Tracking Opioid Prescribing Metrics in Washington State (2012–2017): differences by County-Level Urban-Rural and Economic Distress Classifications. J Rural Health. 2019. doi:10.1111/jrh.12400
   Web of Science ®Google Scholar
• Casser HR, Schaible HG. Musculoskeletal Pain. Schmerz; 2015. doi:10.1007/s00482-015-0046-9
   Google Scholar
• Kuntz B, Hoebel J, Fuchs J, et al. Social inequalities in the prevalence of chronic back pain among adults in Germany. Bundesgesundheitsblatt Gesundheitsforsch - Gesundheitsschutz. 2017;60(7):783–791. doi:10.1007/s00103-017-2568-z
   Web of Science ®Google Scholar
• Gebauer S, Salas J, Scherrer JF. Neighborhood socioeconomic status and receipt of opioid medication for new back pain diagnosis. J Am Board Fam Med. 2017;30(6):775–783. doi:10.3122/jabfm.2017.06.170061
   Web of Science ®Google Scholar
• Kroll LE, Schumann M, Hoebel J, Lampert T. Regional health differences – developing a socioeconomic deprivation index for Germany. J Heath Monit. 2017;2. doi:10.17886/RKI-GBE-2017-035.2.
   Google Scholar
• BKK Dachverband BKK Gesundheits report 2013. Available from: https://www.bkk-dachverband.de/fileadmin/publikationen/gesundheitsreport/fruehere_gesundheitsreporte/BKK-Gesundheitsreport_2013.pdf. Accessed January 5, 2020.
   Google Scholar
• Grobe T, Steinmann S, Szecsenyi J. Barmer GEK Arztreport 2016; 2016. Available from: https://www.barmer.de/blob/36738/41528a9e5704bb8d47e25e00707af4ba/data/pdf-arztreport-2016.pdf. Accessed January 5, 2020.
   Google Scholar
• Kemper C, Sauer K, Glaeske G. BARMER GEK Heil- und Hilfsmittelreport 2012; 2012. Available from: https://www.barmer.de/blob/36980/b7f25ab2fc736e79e68385c5a7064807/data/pdf-report-heil-und-hilfsmittel-2012.pdf. Accessed January 5, 2020.
   Google Scholar
• Wissenschaftliches Institut der AOK (WIdO). Heilmittelreport 2011; 2012. Available from: https://www.wido.de/fileadmin/Dateien/Dokumente/Publikationen_Produkte/Buchreihen/Heilmittelbericht/wido_hei_hmb_2011.pdf. Accessed January 3, 2020.
   Google Scholar
• Schnell M, Currie J. Addressing the opioid epidemic: is there a role for physician education? Am J Health Econ. 2018;4(3):383–410. doi:10.1162/ajhe_a_00113
   Web of Science ®Google Scholar
• Hoffmann F, Icks A. Structural differences between health insurance funds and their impact on health services research: results from the Bertelsmann Health-Care Monitor. Gesundheitswesen. 2012;74. doi:10.1055/s-0031-1275711.
   Web of Science ®Google Scholar
• Hoffmann F, Koller D. Different Regions, Differently Insured Populations? Socio-demographic and Health-related Differences Between Insurance Funds. Gesundheitswesen. 2017;79. doi:10.1055/s-0035-1564074.
   Web of Science ®Google Scholar